D-Wave Quantum Absorbs Six Target Cuts, a Lawsuit and a Bookings Dip

Six brokerages cut their price targets on D-Wave Quantum this week, and not one of them dropped a buy rating. The stock closed Wednesday down 2.8% in a broad sell-off of quantum computing names, capping a week of third-quarter results, a securities class action and a wave of analyst retrenchment.

Stifel lowered its target to $23 from $35 on Wednesday while keeping its buy recommendation. Craig-Hallum went furthest, halving its target to $18 from $40 — the lowest of the six reduced marks — with the rating unchanged. B. Riley Securities had acted a day earlier, trimming to $22 from $27, buy intact. Lower targets, unchanged recommendations: a more guarded form of optimism.

What did the quarter actually show?

Revenue for Q3 2026 came in at $4.5 million, up 21% year on year and ahead of expectations. Bookings moved the other way, falling 19% to $1.9 million. Bookings — the measure of newly signed business — now carries the most weight in the argument over D-Wave's growth trajectory.

The nine-month picture is considerably brighter. Bookings for the first three quarters reached $37.4 million, a gain of 611%. The quarterly loss, however, was $48.2 million, or $0.13 per share, against an expected $0.10 — a three-cent shortfall despite the top-line beat.

Whether the bookings dip proves temporary is the pivot on which the investment thesis turns. A rebound would support the case that D-Wave can convert technical progress into commercial traction. Continued weakness would argue for tempering growth expectations.

What does the lawsuit change?

Pomerantz disclosed on Tuesday that a securities class action has been filed against D-Wave Quantum and certain executives in the US District Court for the Northern District of California. The allegations remain allegations; nothing has been established by any court. Pomerantz has set 15 December 2026 as the deadline for motions seeking appointment as lead plaintiff — a procedural step with limited informational value.

The suit adds a legal dimension to a case investors were already weighing on commercial grounds. How it develops, and whether the operating business produces positive signals in the meantime, is what matters for shareholders.

Can the Stride solver move the numbers?

A potential catalyst arrived on 4 November, when D-Wave announced an improved version of its hybrid Stride solver. According to the company, the new release found better solutions to assembly-line balancing tasks in 15 seconds than the previous version managed in 120 seconds — an eightfold improvement on that workload.

The commercial payoff would come through demand, if customers judge the performance gain valuable enough to pay for. In a favourable scenario, the upgraded offering makes deals easier to close, and recovering order intake strengthens the link between technical development and business results.

Buy, sell or wait?

The cautious reading rests on the earnings line. A wider-than-expected loss means revenue growth loses some of its force unless the underlying economics improve alongside it. In the bear case, soft bookings and earnings pressure coincide, and technical advances offset the drag only once they pay off commercially.

For the bull case to hold, D-Wave must bring technical capability, new business and better earnings together. Until then the stock is a conditional opportunity, gaining substance only if commercial progress follows the technical kind. Forward bookings and earnings figures remain the key catalysts, with the litigation's trajectory part of the risk calculus while the alleged violations stay legally unresolved.